Riskpilot← Back to searchSign inGet full accessFARMAKEION AS
ASActiveOrg 911815427Høyenhallveien 5A, 0667 OsloOther human health activities n.e.c. · NACE 8699Est. 20130 employees
Revenue 2024
NOK 206K
-5% vs 2023
EBITDA margin
92.2%
-9% vs 2023
Equity ratio
86.4%
Financial strength
Net profit 2024
NOK 372K
-65% vs 2023
| Revenue | NOK 206K | -5% |
| EBITDA | NOK 190K | -9% |
| Net profit | NOK 372K | -65% |
| Total assets | NOK 5,8M | +7% |
| Equity | NOK 5M | +8% |
| Employees | 0 | — |
Legal name
FARMAKEION AS
Org number
911815427
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
16. april 2013
Share capital
NOK 490 200
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder hver for seg.
Company purpose
Apotekdrift og andre produkter/tjenester som naturlig hører sammen med dette, herunder å delta i andre selskap med lignende virksomhet, og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak.
Address
Høyenhallveien 5A, 0667 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 217 | 206 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −4 | −6 | −8 | −8 | −11 | −9 | −7 | −7 | −7 | −10 | 209 | 190 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −4 | −6 | −8 | −8 | −11 | −9 | −7 | −7 | −7 | −10 | 209 | 190 |
| Net financials | 0 | 0 | 0 | 0 | 0 | 97 | 243 | 211 | 231 | 2 388 | 881 | 225 |
| Profit before tax | −4 | −6 | −8 | −8 | −11 | 88 | 236 | 204 | 224 | 2 378 | 1 091 | 416 |
| Tax | −1 | −2 | −2 | −0 | 2 | 4 | −0 | −0 | −0 | −0 | 34 | 43 |
| Net profit | −3 | −4 | −6 | −8 | −13 | 84 | 236 | 204 | 224 | 2 378 | 1 056 | 372 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 16 | 12 | 266 | 457 | 644 | 729 | 965 | 1 169 | 1 733 | 4 311 | 5 404 | 5 783 |
| Equity | 16 | 12 | 266 | 258 | 444 | 528 | 765 | 968 | 1 192 | 3 570 | 4 626 | 4 998 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 201 | 541 | 741 | 740 | 740 |
| Short-term debt | 0 | 0 | 0 | 199 | 199 | 199 | 199 | 0 | 0 | 0 | 39 | 45 |
| Total debt | 0 | 0 | 0 | 199 | 199 | 201 | 201 | 201 | 541 | 741 | 778 | 784 |
EBITDA margin
92.2%
This company
15.8%
Market median
+484% vs market
20132024
Equity ratio
86.4%
This company
38.2%
Market median
+126% vs market
20132024
Return on equity
7.4%
This company
18.4%
Market median
-60% vs market
20132024
Net profit margin
180.4%
This company
8.1%
Market median
+2127% vs market
20132024
Asset turnover
0.04×
This company
1.12×
Market median
-96% vs market
20132024
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
20132024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HF Chief Executive Officer | Chief Executive Officer | 2013 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 10.1% | 10.1% | 2022 | |
| Individual | 10.1% | 10.1% | 2022 | |
| Individual | 10.1% | 10.1% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
FARMAKEION AS 
VESTLI APOTEK ASBoard members of FARMAKEION AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Helge Fauskrud | Chief Executive Officer | 0 companies |